Invention Grant
- Patent Title: Synthesis of omecamtiv mecarbil
-
Application No.: US17690729Application Date: 2022-03-09
-
Publication No.: US11702380B2Publication Date: 2023-07-18
- Inventor: Sebastien Caille , James Murray , Kyle Quasdorf , Hannah Nguyen , Maria Victoria Silva Elipe , Ari Elizabeth Ericson
- Applicant: Amgen Inc.
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen Inc.
- Current Assignee: Amgen Inc.
- Current Assignee Address: US CA Thousand Oaks
- Agency: Morrison & Foerster LLP
- Main IPC: C07C201/08
- IPC: C07C201/08
Abstract:
Provided herein are synthetic methods for the preparation of intermediates that are utilized in the synthesis of omecamtiv mecarbil dihydrochloride.
Public/Granted literature
- US20220298099A1 SYNTHESIS OF OMECAMTIV MECARBIL Public/Granted day:2022-09-22
Information query
